[Skip to Content]
[Skip to Content Landing]
Views 336
Citations 0
News From the Food and Drug Administration
January 17, 2017

Relief for Ureteral Obstruction

Author Affiliations
 

Copyright 2017 American Medical Association. All Rights Reserved.

JAMA. 2017;317(3):247. doi:10.1001/jama.2016.19759

A new stent system that could help patients avoid a second invasive procedure to treat severe ureteral obstruction has received FDA approval, according to the device’s manufacturer, BrightWater Medical Inc, Mountain View, California.

Patients with obstructions that prevent urine drainage from the kidneys to the bladder face potential pain, blood in the urine, repeated urinary tract infections, nausea and vomiting, or fever and chills. Severe ureteral obstruction can lead to irreversible kidney damage and may require emergency treatment.

First Page Preview View Large
First page PDF preview
First page PDF preview
×